Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederir.macrogenics.com
MacroGenics, Inc. News Releases
Get the latest updates from MacroGenics, Inc. News Releases directly as they happen.
Follow now 118 followers
Latest posts
Last updated 3 days ago
MacroGenics Announces Date of First Quarter 2025 Financial Results
3 days ago
ROCKVILLE, MD, May 06, 2025 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX),...
MacroGenics to Participate in Upcoming Investor Conference
8 days ago
ROCKVILLE, MD , May 01, 2025 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq...
MacroGenics Provides Update on Corporate Progress and 2024 Financial Results
about 2 months ago
Fully enrolled LORIKEET, a randomized 150-patient Phase 2 study of lorigerlimab in...
MacroGenics Announces Date of Fourth Quarter and Full Year 2024 Financial Results Conference Call
2 months ago
ROCKVILLE, MD , March 06, 2025 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq...
MacroGenics to Participate in Upcoming Investor Conferences
2 months ago
ROCKVILLE, MD , Feb. 27, 2025 (GLOBE NEWSWIRE) -- MacroGenics , Inc...
MacroGenics to Participate in Upcoming Investor Conference
5 months ago
ROCKVILLE, MD , Dec. 02, 2024 (GLOBE NEWSWIRE) -- -- MacroGenics, Inc...
MacroGenics to Participate in Upcoming Investor Conferences
6 months ago
ROCKVILLE, MD , Nov. 06, 2024 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq...
MacroGenics Provides Update on Corporate Progress, Third Quarter 2024 Financial Results
6 months ago
Strengthened financial position resulting from recently announced MARGENZA ® transaction and previously...
MacroGenics Announces Leadership Transition
6 months ago
Scott Koenig , M.D., Ph.D., to step down as President and CEO...
MacroGenics Announces Date of Third Quarter 2024 Financial Results Conference Call
6 months ago
ROCKVILLE, MD , Oct. 29, 2024 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq...
MacroGenics Enters Into Agreement With TerSera Therapeutics for the Sale of MARGENZA®
7 months ago
ROCKVILLE, Md. & DEERFIELD, Ill. --(BUSINESS WIRE)--Oct. 22, 2024-- MacroGenics, Inc. (NASDAQ...
MacroGenics Announces Updated Efficacy & Safety Data from TAMARACK Phase 2 Study of Vobra Duo in mCRPC Patients at ESMO Congress 2024
8 months ago
Encouraging antitumor activity demonstrated with vobra duo as measured by 6-month landmark...